Schedule 13D ownership disclosure

CONNECT BIOPHARMA HLDGS LTD

Security class unavailable · CUSIP: 207523101

Event date: 2021-06-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,991,003
Percent of class
12.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-077775
Form type
SC 13D/A
Filer
Connect Biopharma Holdings Ltd
CIK
CIK 1835268
Filed
Jun 07, 2021
Reporting period
Jun 04, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub